Analysis Ensysce Biosciences, Inc. (ENSC)
6/4/2024
Analysis of Ensysce Biosciences, Inc. (ENSC)
Ensysce Biosciences, Inc. (ENSC) has been showing some volatility in its stock price recently. The Relative Strength Index (RSI) values have been fluctuating around the mid-range, indicating a balanced market sentiment. The Moving Average Convergence Divergence (MACD) histogram has been positive, suggesting a potential bullish momentum.The stock price has been moving within a range, with the Simple Moving Average (SMA) and Exponential Moving Average (EMA) values converging. The Weighted Moving Average (WMA) has been slightly lower than the SMA and EMA, indicating some downward pressure.
Overall, Ensysce Biosciences, Inc. seems to be in a consolidation phase, with mixed signals from technical indicators. Traders and investors may want to closely monitor the price action and wait for a clearer trend to emerge before making any significant trading decisions.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023 (as of September 30, 2023):
- Sales: $383,285,000,000
2. Fiscal Year 2022 (as of September 30, 2022):
- Sales: $394,328,000,000
3. Fiscal Year 2021 (as of September 30, 2021):
- Sales: $365,817,000,000
4. Fiscal Year 2020 (as of September 30, 2020):
- Sales: $274,515,000,000
From the data provided, we can observe that the company's revenue has been increasing over the years, with a significant jump from 2020 to 2021 and a slight decrease in 2023 compared to 2022. This indicates a general trend of revenue growth for the company, with some fluctuations in certain years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,583,000,000.
2. Current assets fluctuate but show an overall increasing trend.
3. Non-current assets have also been increasing steadily.
4. Total liabilities have been increasing, with a slight decrease in 2023 compared to 2022.
5. Shareholders' equity has been fluctuating but generally increasing.
6. The company has been investing in machinery, furniture, and equipment, as seen in the non-current assets section.
7. The company has been managing its debt levels, with both short-term and long-term debts fluctuating over the years.
8. The company has been using cash and cash equivalents for investments, as seen in the current assets section.
9. The company has been retaining earnings and investing in other shareholders' equity.
10. Overall, the company's financial position seems stable and shows signs of growth and investment.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows good returns on assets and equity.
In terms of stock statistics, there is a low short ratio and a significant percentage of shares held by institutions. The stock has a beta of 1.264 and has been trading within a range between its fifty-two-week low and high.
Valuation metrics show a relatively high PEG ratio and forward PE ratio. The company's market capitalization and enterprise value are substantial, with high price to book and price to sales ratios. The enterprise value to EBITDA and revenue ratios are also notable.
The stock price summary includes moving averages, fifty-two-week low and high prices, and the percentage change over the past year.
Dividends and splits information shows the company's dividend dates, split history, and dividend yields. The company has a consistent dividend payout and yield.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant variability, with large amounts being spent on common stock repurchase and debt issuance and payments.
6. Investing activities also vary, with significant amounts being spent on the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company's financial activities show a mix of stability in operations and variability in financing and investing decisions.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This is higher than the EPS of $1.35 from the same quarter last year.
3. For the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This reflects growth from the EPS of $5.67 in the previous fiscal year.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This indicates a potential increase from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates suggest a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth rates expected in the upcoming fiscal year.
Growth estimates
Based on the consensus estimates provided:- The company is expected to experience a growth rate of 7.6% in the current year and 9.7% in the next year.
- For the current quarter and the next quarter, the growth rate is estimated to be around 5.1%.
- Over the next 5 years, the company is projected to have a compound annual growth rate (CAGR) of approximately 9.7%.
- However, when looking at the past 5 years, the company had a higher growth rate of around 20.1% per annum.
Overall, it seems that the company is expected to maintain a solid growth trajectory, although at a slightly lower rate compared to the past 5 years.
Price target
The analysts' forecast for the future price of the security paper is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security paper, with a median forecast above the current price. However, there is a wide range between the low and high forecasts, indicating some uncertainty in the predictions.
MACD of ENSC
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
